EDWARD BLAKE NELSON
Medical Practice in Austin, TX
License number
Pennsylvania MD044850E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Austin, TX 78738
Pennsylvania
Pennsylvania
Personal information
See more information about EDWARD BLAKE NELSON at radaris.comName
Address
Phone
5201 Wolverton Ct, Garland, TX 75043
521 Starling Dr, Desoto, TX 75115
517 Mark Dr, Hanover Township, PA 18706
5027 Rising Sun Dr, Douglassville, PA 19518
500 Grandview Dr, Washington, PA 15301
Professional information
Dr. Edward B Nelson, Austin TX - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
210 Black Wolf Run, Austin 78738
Certifications:
Internal Medicine, 1977
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Texas At Galveston / Medical Branch
U Tex Hosps
University of Texas At Galveston / Medical Branch
U Tex Hosps
Compositions And Methods For Reducing Triglyceride Levels
US Patent:
2010013, May 27, 2010
Filed:
Oct 1, 2009
Appl. No.:
12/572263
Inventors:
Alan Stuart RYAN - Ellicott City MD, US
Edward B. Nelson - Austin TX, US
Jung Lee - McLean VA, US
Krishna Raman - Wilmington DE, US
Edward B. Nelson - Austin TX, US
Jung Lee - McLean VA, US
Krishna Raman - Wilmington DE, US
Assignee:
Martek Biosciences Corporation - Columbia MD
International Classification:
A61K 31/22, A61K 31/202, A61P 3/00
US Classification:
514549, 514560
Abstract:
The present invention is directed to methods of reducing plasma triglyceride level in subjects by administering docosahexaenoic acid (DHA). The method can comprise administering daily to the subject a dosage form comprising docosahexaenoic acid ester substantially free of eicosapentaenoic acid (EPA), wherein the DHA is derived from an algal source. In some embodiments, the method comprises administering daily to the subject a dosage form comprising DHA ester substantially free of EPA, wherein the DHA ester is about 60% to about 99.5% (w/w) of the total fatty acid content of the dosage form. In some embodiments, the method comprises administering daily to the subject a dosage form comprising about 200 mg to about 4 g of DHA ester substantially free of EPA. In some embodiments, the foregoing methods also result in a lowering of the amount of total cholesterol in the subject.